Assessment of the effect of Levothyroxine on volume reduction of Benign thyroid nodule
Phase 2
- Conditions
- Thyroid nodule.Disorders of thyroid glandE00-E07
- Registration Number
- IRCT2014030416828N1
- Lead Sponsor
- Guilan University of Medical Sciences Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients with single nodule or multi nodules ; that has been proved to be benign with FNA.
Exclusion criteria: age under 20 and over 60 ; history of hypo and hyperthyroidism ; history of using Levothyroxine or other related drugs to thyroid ; pregnancy ; other diseases ( cardiovascular or liver disease )
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thyroid nodule size. Timepoint: begining of assessment - six months later. Method of measurement: Ultrasound.
- Secondary Outcome Measures
Name Time Method TSH. Timepoint: before intervention and 6 weeks later and 6 months later. Method of measurement: laboratory kit.